Search results
Sep 11, 2023 · On September 11, 2023, the Food and Drug Administration amended the emergency use authorization (EUA) of Pfizer-BioNTech COVID-19 Vaccine to include the 2023-2024 formula.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate
Benefits to Maintain and Promote Health and Wellness Depending on the customs and laws of a specific country, Pfizer offers colleagues health and wellness programs that help them maintain and promote optimum health and wellness.
Title: Pfizer-BioNTech COVID-19 Vaccine At A Glance: Updated 2023-2024 Formula Author: CDC/NCIRD Subject: Pfizer-BioNTech COVID-19 Vaccine At A Glance: Updated 2023-2024 Formula\r\rGuidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2023 24 Pfizer-BioNTech COVID-19 Vaccine products.\r\r\rCS 321570-AN\rMarch, 20\ 24
Nov 2, 2021 · Pfizer reported that earnings and sales more than doubled in the past quarter, and it raised its outlook for results the full year, thanks greatly to its Covid-19 vaccine.
Sep 15, 2023 · Pfizer’s BNT162b2 mRNA Covid-19 vaccine was the first vaccine against the novel coronavirus (COVID-19) approved for distribution in the United States. The approval came as an emergency use authorization on December 11, 2020, after clinical trials showed the vaccine was 95% effective in preventing COVID-19.
June 15, 2023. Discussing and making recommendations on the selection of strain(s) to be included in the periodic updated COVID-19 vaccines for the 2023-2024 vaccination campaign.
